
 In this episode, James Hamet at Vistim Labs and Duane Mancini discuss licensing technology from a university, voice of customer, neurodegenerative diseases, the importance of your economic story, why they are focusing on clinical data, and so much more.
 James Hamet LinkedIn
  Vistim Labs Website
  Project Medtech Website
  Project Medtech LinkedIn
  Duane Mancini LinkedIn


Episode 143 | James Hamet, CEO at Vistim Labs | Building a Go-To-Market Strategy for an AI Diagnostic

The Project Medtech podcast is interview-style podcast on the Medtech Industry where guests share stories, advice, pitfalls, trends and innovations produced by Project Medtech.

Science

Life Sciences

In this episode, Charles Allan at MY01 and Duane Mancini discuss his background in the Medtech industry, what MY01 is working on, the Medtech Innovator program, focus on collecting clinical data for commercialization support, fundraising strategies as you advance rounds, the Canadian Medtech ecosystem and so much more.

Episode 180 | Charles Allan, Chief Executive Officer at MY01 | Lessons Learned So Far from a Medtech Startup CEO

In this episode, Michelle Lott at LeanRAQA and Duane Mancini discuss the QMSR, FDA e-start program, 513g vs. presubmission meeting, MDR update and so much more.

Episode 179 | Michelle Lott, Principal and Founder at LeanRAQA | FDA and MDR Updates

In this episode, Kevin Saem at Zapyrus and Duane Mancini discuss what Zapyrus does, their 2023 Medtech report on the industry and so much more.

Episode 178 | Kevin Saem, Commercial Director at Zapyrus | 2023 Medtech Report

In this episode, Katrina Holland at MedTech Color and Duane Mancini discuss her new role at MedTech Color, closing the diversity gap in Medtech, her short, medium and long term vision of Medtech Color, and so much more.

Episode 177 | Katrina Holland, Executive Director at MedTech Color | Increasing Diversity in Medtech

In this episode, Ken Callahan at The Hargan Group and Duane Mancini discuss his background with HHS, what startups need to know about the department, what are the biggest policy decisions being discussed right now, how the upcoming election could affect those policies, big issues coming up in 2025 and beyond, and so much more.

Episode 176 | Ken Callahan, Principal at The Hargan Group; Former HHS Chief of Staff to the Deputy Secretary | United States Department of Health and Human Services (HHS)

Episode 143 | James Hamet, CEO at Vistim Labs | Building a Go-To-Market Strategy for an AI Diagnostic

Download our free app to listen on your phone